Medscape Medical NewsAll articles

Philips CT 3500

Philips Healthcare (Suzhou) Co., Ltd • Radiology • 12/22/2022

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The Philips CT 3500 is a versatile X-ray computed tomography system designed for comprehensive diagnostic imaging, including specialized cardiac and lung cancer screening applications, utilizing multi-slice acquisition and advanced image reconstruction algorithms. It operates on the principle of measuring X-ray attenuation through tissues to create detailed cross-sectional anatomical images, with features engineered for both fixed and mobile clinical environments while emphasizing radiation dose management and high image quality.

Summary

The Philips CT 3500 is a whole-body Computed Tomography X-Ray system designed for diagnostic imaging across a wide range of applications, including head, whole body, cardiac (specifically Cardiac Calcium Scoring), and vascular imaging for patients of all ages. It is also indicated for low-dose CT lung cancer screening to facilitate early detection of lung nodules. The system operates by utilizing a continuously rotating X-ray tube and detector array within a gantry to acquire X-ray transmission data from multiple angles and planes around the patient. This acquired data is then processed by a computer to reconstruct cross-sectional images, which can be further analyzed and displayed. The Philips CT 3500 features a 72cm bore, a 50cm scan field of view, and can be deployed in both fixed hospital settings and mobile trailers, supported by a specific 'CT on Trailer Kit'. The fundamental scientific technology of the Philips CT 3500 relies on established principles of X-ray attenuation through tissues, producing images that reflect tissue density variations. Key components include the gantry (housing the X-ray tube, high-voltage generator, and Data Measurement System), a patient table for precise positioning, and an operator console for system control and image review. The system supports various scan modes like axial and helical, and incorporates advanced software for data acquisition, image reconstruction (including deep learning-based 'Precise image'), display, manipulation, storage, and post-processing. Features such as iterative reconstruction (iDose4), metal artifact reduction (O-MAR), and dose modulation techniques (DoseRight Index, 3D-DOM) are integrated to optimize image quality and manage radiation dose effectively. Non-clinical performance data confirmed its adherence to numerous safety and performance standards, with design verification and validation demonstrating its adequacy for intended clinical applications.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Computed Tomography (CT)X-Ray SystemDiagnostic ImagingImage ReconstructionWhole Body ScanningCardiac Calcium ScoringLung Cancer ScreeningMulti-slice CTMobile CTDose Management

Device Metadata

Submission Number
K223311
Company
Philips Healthcare (Suzhou) Co., Ltd
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation|Analysis
AI Subclass
image enhancement|quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the performance of the 32/64 slice configuration of the Philips CT 3500 compare to the predicate's 64/128 slice capability in terms of diagnostic image quality for specific low-contrast applications, given the shared Data Measurement System (DMS) technology?; What are the specific image quality and workflow implications of the slower minimum scan time (0.5 sec vs. 0.35 sec for 360° rotation) of the CT 3500 compared to the Incisive CT, particularly for dynamic or motion-sensitive studies?; Could the 'Precise image' deep learning neural network for noise reduction be further trained or adapted for specific, challenging patient populations or rare pathologies to enhance diagnostic accuracy beyond its current capabilities?; What are the practical advantages and documented limitations of the 'CT on Trailer Kit' for mobile deployment, particularly concerning image quality consistency and system recalibration frequency after transportation under various conditions?; How do the dose optimization features, such as DoseRight Index (DRI) and 3D Dose Modulation (3D-DOM), specifically adapt to pediatric patients of varying body habitus to ensure ALARA principles are met while maintaining diagnostic image quality across the full range of indicated pediatric applications?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score15/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, neural network, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(configuration, deployment, environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Philips CT 3500 - Philips Healthcare (Suzhou) Co., Ltd | ESL FDA AI Device Intelligence